Skip to main content
Premium Trial:

Request an Annual Quote

BGI Partners with Utrecht University, University Medical Center Utrecht

Premium

China's BGI has partnered with Utrecht University and the University Medical Center Utrecht in the Netherlands to conduct genomics research, the institutions said this week.

Under the partnership, the Chinese and Dutch institutes plan to conduct large-scale genome sequencing and functional genomics projects.

Faculty and students at Utrecht University and UMC Utrecht will have access to BGI's expertise, while BGI researchers will be able to use research resources and educational expertise at Utrecht.

BGI said in a statement that it plans to establish further collaborations with institutions in Europe and elsewhere.

BGI's Copenhagen-based European arm is already collaborating with Dutch researchers on the Netherlands Genome Project, an effort to sequence the genomes of 250 family trio samples, or 750 samples in total (IS 7/5/2011). Partners in that project include LifeLines, the ERGO Rotterdam Cohort Study, the Netherlands Twin Registry, and the Leiden Longevity Study.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.